176 related articles for article (PubMed ID: 35251495)
21. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines.
Porath D; Riegger C; Drewe J; Schwager J
J Pharmacol Exp Ther; 2005 Dec; 315(3):1172-80. PubMed ID: 16123309
[TBL] [Abstract][Full Text] [Related]
22. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
Lambert JD; Kwon SJ; Ju J; Bose M; Lee MJ; Hong J; Hao X; Yang CS
Carcinogenesis; 2008 Oct; 29(10):2019-24. PubMed ID: 18684728
[TBL] [Abstract][Full Text] [Related]
23. [The role of NF-E2-related factor 2 in the induction of uridine 5'-diphosphate-glucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells].
Yang XY; Zhao WP; Li YQ; Sun ZY; Zhang Y; Guo YT; Yuan JH; Zhu Q; Wang M
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):82-7. PubMed ID: 16620709
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin-3-Gallate Regulates Anti-Inflammatory Action Through 67-kDa Laminin Receptor-Mediated Tollip Signaling Induction in Lipopolysaccharide-Stimulated Human Intestinal Epithelial Cells.
Byun EB; Kim WS; Sung NY; Byun EH
Cell Physiol Biochem; 2018; 46(5):2072-2081. PubMed ID: 29723847
[TBL] [Abstract][Full Text] [Related]
25. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight.
Scalia S; Marchetti N; Bianchi A
Molecules; 2013 Jan; 18(1):574-87. PubMed ID: 23292326
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB.
Moon YH; Lee JH; Ahn JS; Nam SH; Oh DK; Park DH; Chung HJ; Kang S; Day DF; Kim D
J Agric Food Chem; 2006 Feb; 54(4):1230-7. PubMed ID: 16478241
[TBL] [Abstract][Full Text] [Related]
28. Effect of (-)-Epigallocatechin Gallate to Staphylococcal Enterotoxin A on Toxin Activity.
Shimamura Y; Utsumi M; Hirai C; Kurokawa A; Kan T; Ohashi N; Masuda S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316678
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives.
Zhang X; Wang J; Hu JM; Huang YW; Wu XY; Zi CT; Wang XJ; Sheng J
Molecules; 2016 May; 21(5):. PubMed ID: 27187321
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids.
McLoughlin P; Roengvoraphoj M; Gissel C; Hescheler J; Certa U; Sachinidis A
Genes Cells; 2004 Jul; 9(7):661-9. PubMed ID: 15265009
[TBL] [Abstract][Full Text] [Related]
31. Modifying effects of dietary factors on (-)-epigallocatechin-3-gallate-induced pro-matrix metalloproteinase-7 production in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Ohigashi H
Biosci Biotechnol Biochem; 2007 Oct; 71(10):2442-50. PubMed ID: 17928719
[TBL] [Abstract][Full Text] [Related]
32. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells.
Hu F; Wei F; Wang Y; Wu B; Fang Y; Xiong B
J Pharmacol Sci; 2015 May; 128(1):27-34. PubMed ID: 26003085
[TBL] [Abstract][Full Text] [Related]
33. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
Hong J; Lu H; Meng X; Ryu JH; Hara Y; Yang CS
Cancer Res; 2002 Dec; 62(24):7241-6. PubMed ID: 12499265
[TBL] [Abstract][Full Text] [Related]
34. (-)-Epigallocatechin-3-gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss.
Bitzer ZT; Elias RJ; Vijay-Kumar M; Lambert JD
Mol Nutr Food Res; 2016 Oct; 60(10):2267-2274. PubMed ID: 27218415
[TBL] [Abstract][Full Text] [Related]
35. Preparation of β-lactoglobulin/gum arabic complex nanoparticles for encapsulation and controlled release of EGCG in simulated gastrointestinal digestion model.
Gao J; Mao Y; Xiang C; Cao M; Ren G; Wang K; Ma X; Wu D; Xie H
Food Chem; 2021 Aug; 354():129516. PubMed ID: 33744663
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
37. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate.
Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y
Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300
[TBL] [Abstract][Full Text] [Related]
38. Stability of glycosylated complexes loaded with Epigallocatechin 3-gallate (EGCG).
Zhang J; Cui H; Qiu J; Wang X; Zhong Y; Yao C; Yao L; Zheng Q; Xiong C
Food Chem; 2023 Jun; 410():135364. PubMed ID: 36623458
[TBL] [Abstract][Full Text] [Related]
39. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
[TBL] [Abstract][Full Text] [Related]
40. Position and orientation of gallated proanthocyanidins in lipid bilayer membranes: influence of polymerization degree and linkage type.
Zhu W; Khalifa I; Peng J; Li C
J Biomol Struct Dyn; 2018 Aug; 36(11):2862-2875. PubMed ID: 28844180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
